Urinary Tract Infection Treatment Market Forecast (2024-2031)
The urinary tract infection treatment Market size is projected to reach US$ 13.02 billion by 2031 from US$ 10.10 billion in 2023. The market is expected to register a CAGR of 3.2% in 2022–2031. Development of novel alternative treatments such as nutritional supplements for UTI are likely to remain key urinary tract infection treatment market trends.
Urinary Tract Infection Treatment Market Analysis
Urinary Tract Infections (UTIs) occur when bacteria, mostly from the skin or rectum, enter the urethra and infect the urinary tract. Although several parts of the urinary tract can be affected, the most prevalent type of UTI is a bladder infection (cystitis). Kidney infection (pyelonephritis), on the other hand, is less common but more severe than bladder infections. Growing prevalence of UTIs increase the demand for its prevention and treatment therapies such as antibiotics.
Urinary Tract Infection Treatment Market Overview
Advancements in molecular diagnostics technologies such as remote patient monitoring, and artificial intelligence are expected to enhance the efficiency of diagnostic procedures. A majority of the industry players focus on the development and launch of advanced kits and equipment with an aim to improvise the process of home diagnostics. For instance, in February 2024, PathogenDx, launched its D3 Array-UTI test. This test is a multiplexed PCR test that is capable of detecting 26 different pathogens and 12 antibiotic resistance gene markers. The test results can help clinicians deliver rapid treatment for UTI. Additionally, the rising geriatric population is expected to bring an uptake in the demand for UTI treatments in the coming decade.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Urinary Tract Infection Treatment Market: Strategic Insights
Market Size Value in US$ 9,106.40 Million in 2019 Market Size Value by US$ 11,614.32 Million by 2027 Growth rate CAGR of 3.2% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Urinary Tract Infection Treatment Market: Strategic Insights
![urinary-tract-infection-treatment-market](https://www.theinsightpartners.com/assets/rdimages/urinary-tract-infection-treatment-market-img1.png)
Market Size Value in | US$ 9,106.40 Million in 2019 |
Market Size Value by | US$ 11,614.32 Million by 2027 |
Growth rate | CAGR of 3.2% from 2020-2027 |
Forecast Period | 2020-2027 |
Base Year | 2020 |
![Analyst Image](https://www.theinsightpartners.com/assets/mrinal_kerhalkar.jpg)
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
![Analyst Image](https://www.theinsightpartners.com/assets/images/speak_analyst.gif)
Urinary Tract Infection Treatment Market Drivers and Opportunities
Mounting Cases of UTIs to Favor Market
Increasing prevalence of UTI is one of the prominent factors driving the growth of the urinary tract infection treatment market. For instance, according to a study conducted by a group of researchers at the American College of Physicians and Infectious Diseases Society of America in 2020, UTIs accounts for an estimated 6 million physicians visits each year in the US. Propelling incidences of UTIs is a major driver of global urinary tract infection treatment market share.
Increasing R&D Activities– An Opportunity in UTI Treatment
R&D in UTI treatment is expected to offer lucrative growth opportunities for players in the global urinary tract infection treatment market. Further, in February 2020, a new antibiotic treatment for urinary and bacterial infections, developed by Venatorx Pharmaceuticals and Global Antibiotic Research & Development Partnership (GARDP) is under final review by the FDA. The treatment represents a significant advancement in treating complicated urinary tract infections and serious infections caused by highly resistant bacteria.
Urinary Tract Infection Treatment Market Report Segmentation Analysis
Key segments that contributed to the derivation of the urinary tract infection treatment market analysis are drug class, indication, and distribution channel.
- Based on drug class the market is segmented into penicillin and combinations, quinolones, cephalosporin, aminoglycoside antibiotics, sulphonamides, and nutritional supplements. The quinolones segment held the largest market share in 2023.
- By Indication the market is bifurcated into complicated urinary tract infection and uncomplicated urinary tract infection. The complicated urinary tract infection segment held the largest share of the market in 2023.
- In terms of distribution channel, the market is segmented into hospital pharmacies, gynaecology and urology clinics, retail pharmacies and drug stores, online drug stores. The hospital pharmacies segment dominated the market in 2023.
Urinary Tract Infection Treatment Market Share Analysis by Geography
The geographic scope of the urinary tract infection treatment Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the urinary tract infection treatment Market. The US is estimated to hold the largest share of the North America urinary tract infection treatment market. The growth in the US is estimated due to rising incidence of UTI, the rising development in the field of home diagnostics for UTI, and the presence of the startups offering treatments for UTI. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
Urinary Tract Infection Treatment Market Report Scope
Urinary Tract Infection Treatment Market News and Recent Developments
The urinary tract infection treatment Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for urinary tract infection treatment and strategies:
- Allecra Therapeutics announced U.S. FDA approval for EXBLIFEP for the treatment of complicated urinary tract infections, including pyelonephritis, in patients 18 years and older. The company also received a five-year marketing exclusivity extension from the FDA as part of the Generating Antibiotic Incentives Now Act (GAIN Act). The GAIN Act, enacted by the U.S. Congress, incentivizes the creation of new anti-infective therapeutics by providing benefits to manufacturers of Qualified Infectious Disease Products (QIDPs). (Source: Allecra Therapeutics GmbH, Newsletter, 2024).
- NRx Pharmaceuticals announced that FDA accepts Investigational New Drug (IND) application for its NRX-101 for complicated UTIs. The IND clearance will initiate a phase 2 registrational study to investigate the safety and efficacy of NRX-101 in patients with complicated UTIs. (Source: NRx Pharmaceuticals, Company Website, 2023).
Urinary Tract Infection Treatment Market Report Coverage and Deliverables
The “Urinary Tract Infection Treatment Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
Drug Class , Indication , Distribution Channel , and Geography
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.